NIH-funded research R01 grant

Understanding how specific brain cells help clear debris in white matter degeneration.

Official title: Interrogating a white matter degeneration-specific astrocyte reactivity state and its role in governing repair-associated microglia specification and function.

Funded at Cedars-Sinai Medical Center · NIH-11030312 · Data updated 2026-11-12

This study is looking at how special brain cells work together to help clean up damage in the brain, which could lead to new treatments for people with Multiple Sclerosis and injuries.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startApril 1, 2023
Project endJanuary 31, 2028
Funding year2025
Award (this year)$617,886
NIH project number5R01NS128094-03
Project IDNIH-11030312 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from conditions that involve white matter degeneration, such as Multiple Sclerosis or those recovering from traumatic brain injuries.

Less likely to help

Patients with conditions unrelated to white matter degeneration or those who do not have significant neuroinflammation may not benefit from this research.

What this research studies

This research investigates how certain brain cells, specifically astrocytes, interact with microglia to clear cellular debris in the central nervous system, particularly in conditions like Multiple Sclerosis and traumatic injuries. By using advanced techniques such as single-nucleus RNA sequencing and mouse models, the study aims to uncover the molecular pathways that enhance the brain's ability to repair itself after damage. Patients may benefit from insights that could lead to new therapies aimed at improving debris clearance and reducing inflammation in the brain.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that enhance the brain's repair mechanisms and improve outcomes for patients with white matter degeneration.

How similar studies have gone: Previous research has shown promise in understanding the role of astrocytes and microglia in brain repair, indicating that this approach could yield valuable insights.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Burda, Joshua Evan — Cedars-Sinai Medical Center
  • Study coordinator: Burda, Joshua Evan

Related research

Other NIH-funded projects on the same topics.

  • Lipid signals that control acetyl-CoA and fat metabolism in NAFLD

    A study exploring how membrane lipids influence acetyl-CoA metabolism to understand and potentially treat nonalcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591466

  • Them1’s role in fat metabolism and MASLD progression

    Aims to understand how a fat-regulating protein (Them1) affects energy use in fat and liver, and how this could contribute to MASLD in people who are overweight.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11591395

  • Biomarker-guided Immunosuppression in Kidney Transplant Patients

    A multicenter study in kidney transplant recipients is testing whether a biomarker score from HLA-DR/DQ can guide changes in immunosuppression to reduce rejection risk and drug toxicity.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11550940

  • Alpha5 integrin's role in ALS: how a cell switch worsens disease

    Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

  • Chlamydia pneumoniae infection and Alzheimer's disease progression

    This project looks at whether a common lung infection, Chlamydia pneumoniae, might influence Alzheimer's disease in people and what that could mean for treatment.

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11538116

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.